Open access · CC-BY
via OpenAlex
Senescence in Vascular Smooth Muscle Cells and Atherosclerosis
Yiwen Zha, Wenwen Zhuang, Yongqi Yang, Yue Zhou, Hongliang Li, Jingyan Liang
Frontiers in Cardiovascular Medicine · 2022 · ▲ 50 citations
Abstract
Vascular smooth muscle cells (VSMCs) are the primary cell type involved in the atherosclerosis process; senescent VSMCs are observed in both aged vessels and atherosclerotic plaques. Factors associated with the atherosclerotic process, including oxidative stress, inflammation, and calcium-regulating factors, are closely linked to senescence(definition) in VSMCs. A number of experimental studies using traditional cellular aging markers have suggested that anti-aging biochemical agents could be used to treat atherosclerosis. However, doubt has recently been cast on such potential due to the increasingly apparent complexity of VSMCs status and an incomplete understanding of the role that these cells play in the atherosclerosis process, as well as a lack of specific or spectrum-limited cellular aging markers. The utility of anti-aging drugs in atherosclerosis treatment should be reevaluated. Promotion of a healthy lifestyle, exploring in depth the characteristics of each cell type associated with atherosclerosis, including VSMCs, and development of targeted drug delivery systems will ensure efficacy whilst evaluation of the safety and tolerability of drug use should be key aims of future anti-atherosclerosis research. This review summarizes the characteristics of VSMC senescence during the atherosclerosis process, the factors regulating this process, as well as an overview of progress toward the development and application of anti-aging drugs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fcvm.2022.910580
- Canonical
- link ↗
- Fetched
- 2026-09-16 MST
Cite this
APA
Zha, Y., Zhuang, W., Yang, Y., Zhou, Y., Li, H., & Liang, J. (2022). Senescence in Vascular Smooth Muscle Cells and Atherosclerosis. <em>Frontiers in Cardiovascular Medicine</em>. https://doi.org/10.3389/fcvm.2022.910580
Vancouver
Zha Y, Zhuang W, Yang Y, Zhou Y, Li H, Liang J. Senescence in Vascular Smooth Muscle Cells and Atherosclerosis. Frontiers in Cardiovascular Medicine. 2022. doi:10.3389/fcvm.2022.910580.
BibTeX
@article{yiwen2022Senesc,
title = {Senescence in Vascular Smooth Muscle Cells and Atherosclerosis},
author = {Yiwen Zha and Wenwen Zhuang and Yongqi Yang and Yue Zhou and Hongliang Li and Jingyan Liang},
journal = {Frontiers in Cardiovascular Medicine},
year = {2022},
doi = {10.3389/fcvm.2022.910580},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biogerontology 2025
Open access · CC-BY
Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects
Cellular signalling 2026
Citation only
The anti-aging drug Senolytics alleviates vascular endothelial cell senescence by antagonizing the JPX-BRD4-p65 complex.
Central Asian Journal of Medical Hypotheses and Ethics 2025
Open access · CC-BY
SENOLYTICS AND SENOMORPHICS: A NEW CLASS OF DRUGS FOR ANTI-AGING THERAPY
Geriatrics Gerontology and Aging 2024
Open access · CC-BY
Moving from an “anti-aging” paradigm toward the concept of “disease-free aging”: the role of senolytics in modern medicine
Ageing Research Reviews 2024
Open access · CC-BY
Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
Biomedical Research and Therapy 2024
Open access · CC-BY